Selectin E/CD62e Antikörper (AA 501-612)
Kurzübersicht für Selectin E/CD62e Antikörper (AA 501-612) (ABIN674244)
Target
Alle Selectin E/CD62e (SELE) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 501-612
- 
                                            Kreuzreaktivität
- Human, Maus, Schwein, Ratte
- 
                                            Homologie
- Dog,Horse,Chicken,Rabbit
- 
                                            Aufreinigung
- Purified by Protein A.
- 
                                            Immunogen
- KLH conjugated synthetic peptide derived from mouse E-Selectin
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        WB 1:300-5000
 ELISA 1:500-1000
 FCM 1:20-100
 IHC-P 1:200-400
 IHC-F 1:100-500
 IF(IHC-P) 1:50-200
 IF(IHC-F) 1:50-200
 IF(ICC) 1:50-200
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 1 μg/μL
- 
                                            Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            Lagerung
- 4 °C,-20 °C
- 
                                            Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 
                                            Haltbarkeit
- 12 months
 
- 
                                            
- 
    - 
                                            : "Role of the plasma cascade systems in ischemia/reperfusion injury of bone."    in: Bone, Vol. 97, pp. 278-286, (2017)         (PubMed).        
 : "Facilitatory effects of fetuin-A on atherosclerosis." in: Atherosclerosis, Vol. 246, pp. 344-51, (2016) (PubMed).
 : "CD44 fucosylation on mesenchymal stem cell enhances homing and macrophage polarization in ischemic kidney injury." in: Experimental cell research, Vol. 350, Issue 1, pp. 91-102, (2016) (PubMed).
 : "Atorvastatin protects against cerebral ischemia/reperfusion injury through anti-inflammatory and antioxidant effects." in: Neural regeneration research, Vol. 9, Issue 3, pp. 268-75, (2014) (PubMed).
 : "The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits." in: Lipids in health and disease, Vol. 12, pp. 115, (2013) (PubMed).
 
 
- 
                                            : "Role of the plasma cascade systems in ischemia/reperfusion injury of bone."    in: Bone, Vol. 97, pp. 278-286, (2017)         (PubMed).        
- 
    - Selectin E/CD62e (SELE) (Selectin E (SELE))
- 
                                            Andere Bezeichnung
- E-Selectin/CD62E
- 
                                            Hintergrund
- 
                        Synonyms: Elam, CD62E, E-selectin, CD62 antigen-like family member E, Endothelial leukocyte adhesion molecule 1, ELAM-1, Leukocyte-endothelial cell adhesion molecule 2, LECAM2, Sele Background: Cell-surface glycoprotein having a role in immunoadhesion. Mediates in the adhesion of blood neutrophils in cytokine-activated endothelium through interaction with PSGL1/SELPLG. May have a role in capillary morphogenesis. 
- 
                                            Gen-ID
- 20339
- 
                                            UniProt
- Q00690
- 
                                            Pathways
- Thromboxane A2 Receptor Signaling
 Target
- 
                    
 
                                     
                                     
                                    